Clinical Trials Directory

Trials / Sponsors / Tetra Discovery Partners

Tetra Discovery Partners

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome
Fragile X Syndrome
Phase 32022-11-01
Active Not RecruitingAn Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
Fragile X Syndrome
Phase 32022-11-01
CompletedA Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome
Fragile X Syndrome
Phase 2 / Phase 32022-03-29
WithdrawnA Phase 1, Open-Label, PET Study of T2310 & BPN14770
To Determine Brain Target Occupancy of BPN14770
Phase 12020-01-10
CompletedTetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects
Alzheimer's Disease
Phase 22019-04-30
CompletedA 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
Fragile X Syndrome, FXS, Fra(X) Syndrome
Phase 22018-07-09
CompletedStudy to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers
Alzheimer Disease
Phase 12017-01-01
CompletedA Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects
Alzheimer's Disease
Phase 12016-06-01
CompletedBPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects
Alzheimer's Disease
Phase 12015-12-01